Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission
leading to generalized or localized muscle weakness due most frequently to the presence of …

Myasthenia gravis (MG) has been recognized as a series of heterogeneous but treatable
autoimmune conditions. As one of the indispensable therapies, thymectomy can achieve …

In recent years, thymectomy has become a widespread procedure in the treatment of
myasthenia gravis (MG). Likelihood of remission was highest in preoperative mild disease …

Background Despite the burgeoning literature describing preoperative and postoperative
risks of a myasthenic crisis after thymectomy (MCAT) in patients with myasthenia gravis …

OBJECTIVES Postoperative myasthenic crisis (POMC) is one of the serious complications
after extended thymectomy for patients with myasthenia gravis (MG). This study aims to …

Objective Myasthenic crisis (MC) is considered the most severe adverse event in patients
with myasthenia gravis. The present retrospective study was performed to evaluate the …

Background: The purpose of the study was to determine the risk factors of post-surgery
myasthenia crisis (PMC) among myasthenia gravis (MG) patients. Methods: A meta-analysis …

Background Approaches of thoracoscopic thymectomy for myasthenia gravis (MG) are
debatable. The subxiphoid approach is widely utilized recent years for its better visualization …

Purpose: The aims of this study were to assess the clinical characteristics of patients with
postoperative myasthenic crisis (PMC) and to identify the risk factors affecting the …

Purpose: Thymectomy is the first-line therapy for thymomatous myasthenia gravis patients.
The aim of this study is to explore the clinical outcome and predictors of postoperative …